These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8821598)

  • 21. Activity of LY333328 in experimental meningitis caused by a Streptococcus pneumoniae strain susceptible to penicillin.
    Gerber J; Smirnov A; Wellmer A; Ragheb J; Prange J; Schütz E; Wettich K; Kalich S; Nau R
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2169-72. PubMed ID: 11408247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
    J Antimicrob Chemother; 2002 Feb; 49(2):327-30. PubMed ID: 11815575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental study of the efficacy of daptomycin for the treatment of cephalosporin-resistant pneumococcal meningitis.
    Vivas M; Force E; Garrigós C; Tubau F; Platteel AC; Ariza J; Cabellos C
    J Antimicrob Chemother; 2014 Nov; 69(11):3020-6. PubMed ID: 24962033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis.
    Martínez-Lacasa J; Cabellos C; Martos A; Fernández A; Tubau F; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2002 Mar; 49(3):507-13. PubMed ID: 11864951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.
    Rodriguez-Cerrato V; Ghaffar F; Saavedra J; Michelow IC; Hardy RD; Iglehart J; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3098-103. PubMed ID: 11600362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
    Ostergaard C; Sørensen TK; Knudsen JD; Frimodt-Møller N
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1706-12. PubMed ID: 9661008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
    Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P
    J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of dexamethasone on the efficacy of daptomycin in the therapy of experimental pneumococcal meningitis.
    Vivas M; Force E; Tubau F; El Haj C; Ariza J; Cabellos C
    Int J Antimicrob Agents; 2015 Jul; 46(1):28-32. PubMed ID: 25813395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo.
    Sande MA; Korzeniowski OM; Allegro GM; Brennan RO; Zak O; Scheld WM
    Rev Infect Dis; 1981; 3(1):98-109. PubMed ID: 7221361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rifampin for therapy of experimental pneumococcal meningitis in rabbits.
    Nau R; Kaye K; Sachdeva M; Sande ER; Täuber MG
    Antimicrob Agents Chemother; 1994 May; 38(5):1186-9. PubMed ID: 8067762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of quinupristin/dalfopristin against Streptococcus pneumoniae in vitro and in vivo in the rabbit model of experimental meningitis.
    Tarasi A; Dever LL; Tomasz A
    J Antimicrob Chemother; 1997 May; 39 Suppl A():121-7. PubMed ID: 9511076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.
    Nau R; Zysk G; Schmidt H; Fischer FR; Stringaris AK; Stuertz K; Brück W
    J Antimicrob Chemother; 1997 Jun; 39(6):781-8. PubMed ID: 9222048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.
    Klugman KP; Friedland IR; Bradley JS
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1988-92. PubMed ID: 8540704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall.
    Stucki A; Cottagnoud M; Winkelmann V; Schaffner T; Cottagnoud P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2249-52. PubMed ID: 17371817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamics of gatifloxacin in experimental models of pneumococcal meningitis.
    McCracken GH
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S45-50. PubMed ID: 10984328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
    Chavanet P; Beloeil H; Pechinot A; Duigou F; Buisson JC; Duong M; Neuwirth C; Kazmierczak A; Portier H
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1736-43. PubMed ID: 7486911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gemifloxacin is effective in experimental pneumococcal meningitis.
    Smirnov A; Wellmer A; Gerber J; Maier K; Henne S; Nau R
    Antimicrob Agents Chemother; 2000 Mar; 44(3):767-70. PubMed ID: 10681354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.
    París MM; Shelton S; Trujillo M; Hickey SM; McCracken GH
    Antimicrob Agents Chemother; 1996 Jan; 40(1):122-6. PubMed ID: 8787892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.
    Grandgirard D; Schürch C; Cottagnoud P; Leib SL
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2173-8. PubMed ID: 17371820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model.
    Cottagnoud P; Gerber CM; Acosta F; Cottagnoud M; Neftel K; Täuber MG
    J Antimicrob Chemother; 2000 Dec; 46(6):981-5. PubMed ID: 11102418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.